Tag Archives: NASDAQ:CRSP

William Blair Thinks Crispr Therapeutics AG’s Stock is Going to Recover

William Blair analyst Raju Prasad maintained a Buy rating on Crispr Therapeutics AG (CRSP – Research Report) today. The company’s shares closed last Tuesday at $102.59, close to its 52-week low of $84.38. According to TipRanks.com, Prasad is a 4-star

Analysts Offer Insights on Healthcare Companies: Crispr Therapeutics AG (NASDAQ: CRSP) and Alector (NASDAQ: ALEC)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Crispr Therapeutics AG (CRSP – Research Report) and Alector (ALEC – Research Report) with bullish sentiments. Crispr Therapeutics AG (CRSP) Barclays analyst

Analysts Offer Insights on Healthcare Companies: Crispr Therapeutics AG (NASDAQ: CRSP), Brainsway (NASDAQ: BWAY) and Cormedix (NASDAQ: CRMD)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Crispr Therapeutics AG (CRSP – Research Report), Brainsway (BWAY – Research Report) and Cormedix (CRMD – Research Report) with bullish sentiments. Crispr

Needham Believes Crispr Therapeutics AG (NASDAQ: CRSP) Still Has Room to Grow

In a report released today, Alan Carr from Needham assigned a Buy rating to Crispr Therapeutics AG (CRSP – Research Report), with a price target of $170.00. The company’s shares closed last Wednesday at $146.63, close to its 52-week high

William Blair Believes Crispr Therapeutics AG (NASDAQ: CRSP) Won’t Stop Here

In a report released today, Raju Prasad from William Blair maintained a Buy rating on Crispr Therapeutics AG (CRSP – Research Report). The company’s shares closed last Friday at $147.54, close to its 52-week high of $151.11. According to TipRanks.com,

Crispr Therapeutics AG (CRSP) Gets a Sell Rating from Raymond James

In a report issued on June 12, Steven Seedhouse from Raymond James maintained a Sell rating on Crispr Therapeutics AG (CRSP – Research Report). The company’s shares closed last Thursday at $96.35. According to TipRanks.com, Seedhouse is a 4-star analyst